{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "17652311", "DateCompleted": {"Year": "2008", "Month": "01", "Day": "14"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [{"Year": "2007", "Month": "07", "Day": "25"}], "Journal": {"ISSN": "0903-1936", "JournalIssue": {"Volume": "30", "Issue": "4", "PubDate": {"Year": "2007", "Month": "Oct"}}, "Title": "The European respiratory journal", "ISOAbbreviation": "Eur Respir J"}, "ArticleTitle": "Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes.", "Pagination": {"StartPage": "677", "EndPage": "683", "MedlinePgn": "677-83"}, "Abstract": {"AbstractText": ["Chronic exposure to ozone (O(3)) can cause changes in lung function that may reflect remodelling of small airways. It is likely that antioxidant enzyme function affects susceptibility to O(3). The aim of the present study was to determine whether polymorphisms in antioxidant enzyme (GSTM1, GSTP1 and NQO1) genes affect the risk of lung function changes related to chronic exposure to O(3). In total, 210 young adults who participated in a previous study, which showed a relationship between lifetime exposure to O(3) and decreased lung function, were genotyped. Multivariable linear regression was used to model sex-specific associations between genotypes and O(3)-related lung function changes, adjusting for height, weight, lifetime exposure to nitrogen dioxide and particles with a 50% cut-off aerodynamic diameter of 10 mum, and self-identified race/ethnicity. The GSTM1-null/NQO1 Pro187Pro-combination genotype was significantly associated with increased risk of an O(3)-related decrease in mean forced expiratory flow between 25-75% of forced vital capacity in females (parameter estimate+/-se -75+/-35 mL.s(-1)), while the GSTP1 Val105 variant genotypes were significantly associated with greater risk of an O(3)-related decrease in mean forced expiratory flow at 75% of forced vital capacity in males (-81+/-31 mL.s(-1)). GSTM1-null status was not significantly associated with any O(3)-related changes in lung function in either sex. The current authors conclude that the effects of antioxidant enzyme gene polymorphisms on the risk of decreased lung function related to chronic exposure to ozone may be modified by sex-specific factors."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Public Health, University of California, San Francisco, CA 94143-0843, USA."}], "Identifier": [], "LastName": "Chen", "ForeName": "C", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Arjomandi", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tager", "ForeName": "I B", "Initials": "IB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Holland", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Balmes", "ForeName": "J R", "Initials": "JR"}], "GrantList": [{"GrantID": "K23 HL083099-02", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "L30 HL082326-03", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL083099-04", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "L30 HL082326-01", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL83099", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL083099-03", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL60689", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL083099", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "L30 HL082326", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "L30 HL082326-02", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL083099-01A1", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K23 HL083099-05", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Eur Respir J", "NlmUniqueID": "8803460", "ISSNLinking": "0903-1936"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 2.5.1.18", "NameOfSubstance": "Glutathione S-Transferase pi"}, {"RegistryNumber": "EC 2.5.1.18", "NameOfSubstance": "Glutathione Transferase"}, {"RegistryNumber": "EC 2.5.1.18", "NameOfSubstance": "glutathione S-transferase M1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Alleles"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Forced Expiratory Volume"}, {"QualifierName": [], "DescriptorName": "Genetic Predisposition to Disease"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": ["genetics"], "DescriptorName": "Glutathione S-Transferase pi"}, {"QualifierName": ["genetics"], "DescriptorName": "Glutathione Transferase"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Multivariate Analysis"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Polymorphism, Genetic"}, {"QualifierName": [], "DescriptorName": "Sex Factors"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000;21:1\u201348.", "ArticleIdList": ["10804262"]}, {"Citation": "Gerrity TR, Weaver RA, Berntsen J, House DE, O\u2019Neil JJ. Extrathoracic and intrathoracic removal of O3 in tidal-breathing humans. J Appl Physiol. 1988;65:393\u2013400.", "ArticleIdList": ["3403482"]}, {"Citation": "Overton JH, Graham RC, Miller FJ. A model of the regional uptake of gaseous pollutants in the lung. II. The sensitivity of ozone uptake in laboratory animal lungs to anatomical and ventilatory parameters. Toxicol Appl Pharmacol. 1987;88:418\u2013432.", "ArticleIdList": ["3576624"]}, {"Citation": "Pryor WA. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic Biol Med. 1992;12:83\u201388.", "ArticleIdList": ["1537573"]}, {"Citation": "Pryor WA, Squadrito GL, Friedman M. A new mechanism for the toxicity of ozone. Toxicol Lett. 1995;82\u201383:287\u2013293.", "ArticleIdList": ["8597067"]}, {"Citation": "Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med. 1995;19:935\u2013941.", "ArticleIdList": ["8582671"]}, {"Citation": "Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis. 1993;148:1363\u20131372.", "ArticleIdList": ["8239177"]}, {"Citation": "Christian DL, Chen LL, Scannell CH, Ferrando RE, Welch BS, Balmes JR. Ozone-induced inflammation is attenuated with multiday exposure. Am J Respir Crit Care Med. 1998;158:532\u2013537.", "ArticleIdList": ["9700132"]}, {"Citation": "Arjomandi M, Witten A, Abbritti E, et al. Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. Am J Respir Crit Care Med. 2005;172:427\u2013432.", "ArticleIdList": ["PMC2718526", "15937293"]}, {"Citation": "K\u00fcnzli N, Lurmann F, Segal M, Ngo L, Balmes J, Tager IB. Association between lifetime ambient ozone exposure and pulmonary function in college freshmen \u2013 results of a pilot study. Environ Res. 1997;72:8\u201323.", "ArticleIdList": ["9012368"]}, {"Citation": "Tager IB, Balmes J, Lurmann F, Ngo L, Alcorn S, K\u00fcnzli N. Chronic exposure to ambient ozone and lung function in young adults. Epidemiology. 2005;16:751\u2013759.", "ArticleIdList": ["16222164"]}, {"Citation": "Koren HS, Devlin RB, Graham DE, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis. 1989;139:407\u2013415.", "ArticleIdList": ["2913889"]}, {"Citation": "Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning) Free Radic Res. 1999;31:261\u2013272.", "ArticleIdList": ["10517532"]}, {"Citation": "MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:50\u201360.", "ArticleIdList": ["16113469"]}, {"Citation": "Kelly FJ. Vitamins and respiratory disease: antioxidant micronutrients in pulmonary health and disease. Proc Nutr Soc. 2005;64:510\u2013526.", "ArticleIdList": ["16313695"]}, {"Citation": "Kleeberger SR. Genetic susceptibility to ozone exposure. Toxicol Lett. 1995;82\u201383:295\u2013300.", "ArticleIdList": ["8597068"]}, {"Citation": "McDonnell WF. Intersubject variability in human acute ozone responsiveness. Pharmacogenetics. 1991;1:110\u2013113.", "ArticleIdList": ["1844868"]}, {"Citation": "Balmes JR, Chen LL, Scannell C, et al. Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med. 1996;153:904\u2013909.", "ArticleIdList": ["8630571"]}, {"Citation": "Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482:21\u201326.", "ArticleIdList": ["11535245"]}, {"Citation": "Gilliland FD, Li YF, Dubeau L, et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med. 2002;166:457\u2013463.", "ArticleIdList": ["12186820"]}, {"Citation": "Bergamaschi E, De Palma G, Mozzoni P, et al. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am J Respir Crit Care Med. 2001;163:1426\u20131431.", "ArticleIdList": ["11371413"]}, {"Citation": "Romieu I, Sienra-Monge JJ, Ram\u00edrez-Aguilar M, et al. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax. 2004;59:8\u201310.", "ArticleIdList": ["PMC1758856", "14694237"]}, {"Citation": "Romieu I, Ramirez-Aguilar M, Sienra-Monge JJ, et al. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J. 2006;28:953\u2013959.", "ArticleIdList": ["16870661"]}, {"Citation": "Piirila P, Wikman H, Luukkonen R, et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics. 2001;11:437\u2013445.", "ArticleIdList": ["11470996"]}, {"Citation": "David GL, Romieu I, Sienra-Monge JJ, et al. Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma. Am J Respir Crit Care Med. 2003;168:1199\u20131204.", "ArticleIdList": ["12969868"]}, {"Citation": "Gilliland FD, Rappaport EB, Berhane K, et al. Effects of glutathione S-transferase P1, M1, and T1 on acute respiratory illness in school children. Am J Respir Crit Care Med. 2002;166:346\u2013351.", "ArticleIdList": ["12153968"]}, {"Citation": "Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med. 2002;166:710\u2013716.", "ArticleIdList": ["12204870"]}, {"Citation": "Gilliland FD, Li YF, Saxon A, Diaz-Sanchez D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet. 2004;363:119\u2013125.", "ArticleIdList": ["14726165"]}, {"Citation": "K\u00fcnzli N, Lurman F, Segal M, Ngo L, Balmes J, Tager IB. Reliability of lifetime residential history and activity measures as elements of cumulative ambient ozone exposure assessment. J Expo Anal Environ Epidemiol. 1996;6:289\u2013310.", "ArticleIdList": ["8889950"]}, {"Citation": "Tager IB, K\u00fcnzli N, Lurmann F, Ngo L, Segal M, Balmes J. Methods development for epidemiologic investigations of the health effects of prolonged ozone exposure. Part II. An approach to retrospective estimation of lifetime ozone exposure using a questionnaire and ambient monitoring data (California sites) Res Rep Health Eff Inst. 1998;81:27\u201378.", "ArticleIdList": ["9643947"]}, {"Citation": "Tujague J, Bastaki M, Holland N, Balmes JR, Tager IB. Antioxidant intake, GSTM1 polymorphism and pulmonary function in healthy young adults. Eur Respir J. 2006;27:282\u2013288.", "ArticleIdList": ["16452581"]}, {"Citation": "Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107\u20131136.", "ArticleIdList": ["7663792"]}, {"Citation": "Tager IB, Weiss ST, Munoz A, Welty C, Speizer FE. Determinants of response to eucapneic hyperventilation with cold air in a population-based study. Am Rev Respir Dis. 1986;134:502\u2013508.", "ArticleIdList": ["3092709"]}, {"Citation": "Mead J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis. 1980;121:339\u2013342.", "ArticleIdList": ["7362140"]}, {"Citation": "Pellegrino R, Viegi G, Brusasco, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948\u2013968.", "ArticleIdList": ["16264058"]}, {"Citation": "Hoensch H, Peters WH, Roelofs HM, Kirch W. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age. Curr Med Res Opin. 2006;22:1075\u20131083.", "ArticleIdList": ["16846540"]}, {"Citation": "Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445\u2013600.", "ArticleIdList": ["8770536"]}, {"Citation": "Corradi M, Alinovi R, Goldoni M, et al. Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol Lett. 2002;134:219\u2013225.", "ArticleIdList": ["12191881"]}]}], "History": [{"Year": "2007", "Month": "7", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "1", "Day": "15", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "7", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2012", "Month": "2", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17652311", "NIHMS349872", "PMC3282174", "10.1183/09031936.00160806", "09031936.00160806"]}}], "PubmedBookArticle": []}